The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-N-(1-(4-methoxyphenyl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide ID: ALA4875425
PubChem CID: 164627211
Max Phase: Preclinical
Molecular Formula: C21H21N5O2
Molecular Weight: 375.43
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc([C@H](C)NC(=O)c2cnc3ccc(-c4cnn(C)c4)cn23)cc1
Standard InChI: InChI=1S/C21H21N5O2/c1-14(15-4-7-18(28-3)8-5-15)24-21(27)19-11-22-20-9-6-16(13-26(19)20)17-10-23-25(2)12-17/h4-14H,1-3H3,(H,24,27)/t14-/m0/s1
Standard InChI Key: XFBQGNNACTXBPY-AWEZNQCLSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
24.1237 -4.7050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1237 -5.5222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8289 -5.9267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8289 -4.2923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5342 -4.7050 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.5342 -5.5187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3080 -5.7702 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.7864 -5.1119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3081 -4.4537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4171 -4.2994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3293 -3.4869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5295 -3.3194 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.1229 -4.0283 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.6716 -4.6339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3105 -4.1162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5606 -3.6765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3600 -3.5066 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.0138 -3.0692 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.6125 -2.7294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4119 -2.5596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0657 -2.1221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9568 -3.1690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7555 -2.9996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0088 -2.2217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4572 -1.6131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6606 -1.7856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8079 -2.0508 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.3555 -2.6574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 2 0
2 3 2 0
3 6 1 0
5 4 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 5 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 10 2 0
1 10 1 0
13 15 1 0
9 16 1 0
16 17 1 0
16 18 2 0
19 17 1 1
19 20 1 0
19 21 1 0
20 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 20 1 0
24 27 1 0
27 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 375.43Molecular Weight (Monoisotopic): 375.1695AlogP: 3.23#Rotatable Bonds: 5Polar Surface Area: 73.45Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 4.48CX LogP: 1.81CX LogD: 1.81Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.58Np Likeness Score: -1.71
References 1. Zhang Y, Xia A, Zhang S, Lin G, Liu J, Chen P, Mu B, Jiao Y, Xu W, Chen M, Li L.. (2021) Discovery of 3,6-disubstutited-imidazo[1,2-a]pyridine derivatives as a new class of CLK1 inhibitors., 41 [PMID:33662541 ] [10.1016/j.bmcl.2021.127881 ]